BIOBANK ŁUKASIEWICZ – PORT CLOSER TO CLINICAL RESEARCH, CLOSER TO THE PATIENT

Competition for the establishment of Regional Centers for Digital Medicine (RCMCs) settled. The Polish Medical Research Agency (ABM) has selected 18 entities to implement projects for the digitization of clinical research. Nearly PLN 60 million will go to a consortium of which the Research Group Biobank Łukasiewicz – PORT, led by Patrycja Gazińska, PhD, is a part. For Biobank, the two grants awarded mean the development of infrastructure, acceleration of scientific activities within the Center being created, as well as a shift towards translational medicine.

The Agency for Medical Research (ABM) is a state institution responsible for the development of research in medical and health sciences. Its mission is to create an innovative digital health infrastructure that contributes to improving the way patient care is delivered across the European Union.

The creation of the RCMCs is intended to serve both more secure data analysis, support clinical research and hospital care in the area of digital solutions, and retrospective analysis.

The strength of consortium

Biobank Łukasiewicz – PORT has received grants for projects that promise to extend its activities to a cooperation over clinical research. An invaluable benefit of participating in the projects will also be the extensive and close cooperation with the consortium leaders – important clinical units in the region:

1. the 4th Military Clinical Hospital with Polyclinic SP ZOZ in Wrocław, with which Biobank will implement the project entitled: Establishment and development of an integrated system for the analysis and management of structured clinical and multiomic data based on artificial intelligence in civilizational diseases.

2. the University Clinical Hospital in Opole. Project title: University Centre for Digital Medicine and Precision Medicine with specialization in complex phenotyping of civilization diseases.

As part of the consortia, Biobank will cooperate not only with hospitals, but also with other highly regarded scientific and research units: Wrocław University of Technology, the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław, the Institute of Human Genetics of the Polish Academy of Sciences in Poznań and the Institute of Bioorganic Chemistry of the Polish Academy of Sciences Supercomputing and Networking Centre in Poznań and the University of Opole.

The basis for cooperation between the units associated in the consortia, in addition to clinical research, will be complex data analysis using artificial intelligence and machine learning. Detailed information about the competition on the ABM website.